LYFE Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 17

Professionals

  • Investments
  • 145

  • Portfolio
  • 82

  • Exits
  • 24

Exits

LYFE Capital General Information

Company Description

Founded in 2015, LYFE Capital is a venture capital firm based in Shanghai, China. The firm seeks to invest in the biotechnology, pharmaceutical, medical devices, and healthcare sectors.

Business Details

Year Founded
2015
Investor Status
Actively Seeking New Investments
Trade Association
Hong Kong Venture Capital Association (HKVC)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Corporate Office
  • Park Place, 1601 West Nanjing Road
  • Suite 3204-3205
  • Shanghai, 200040
  • China
+86 021 0000 0000

LYFE Capital Investments (145)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Arnatar Therapeutics 08-Apr-2024 Early Stage VC 0000 Drug Discovery Generating Revenue
ProfoundBio 09-Feb-2024 00000 00000 00000 Drug Discovery Clinical Trials - Phase 2
Neurona Therapeutics 06-Feb-2024 00000 00000 00000 Biotechnology Clinical Trials - Phase 1
ChemLex 09-Jan-2024 00000 00000 0000 Computers, Parts and Peripherals Generating Revenue 0000 00 00.0
Anlingke Biomedicine 10-Nov-2023 0000 00000 Drug Discovery Startup
Kyverna 06-Nov-2023 00000 00000 00000 Biotechnology Generating Revenue/Not Profitable
Fong's Engineering & Manufacturing 13-Oct-2023 0000000000 BPO/Outsource Services Generating Revenue 0000 0000 00
HC Scientific 28-Aug-2023 00000 00000 000.00 Diagnostic Equipment Generating Revenue
Haotian Pharmatech 05-Jul-2023 Later Stage VC 000.00 Pharmaceuticals Profitable
Yilite Technology 30-Jun-2023 Seed Round 0000 Electrical Equipment Generating Revenue
You’re viewing 10 of 145 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LYFE Capital Exits (24)

Company Name Exit Date Exit Type Exit Size
ProfoundBio 21-May-2024 Merger/Acquisition 00.00
Kyverna 08-Feb-2024 000 00000
ImmuneOnco 05-Sep-2023 000 000.00
Canopus Medical 30-Nov-2022 000 00000
R&G PharmaStudies 02-Aug-2022 000 00000
RecBio 30-Mar-2022 000 000.00
CANbridge Pharma 10-Dec-2021 000 000.00
AoHua 15-Nov-2021 000 00000
Immuneering 30-Jul-2021 IPO 00000
Cytek 23-Jul-2021 IPO 00000
You’re viewing 10 of 24 exits. Get the full list »

LYFE Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore LYFE Capital‘s full profile, request access.

Request a free trial

LYFE Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

LYFE Capital Management, Team & Partners (24)

Name Title Deals Funds Boards Office
Roy Xu Chief Financial Officer Shanghai, China
Derek Yuan Ph.D Managing Director 0 0 Shanghai, China
Tian Jing Managing Director Menlo Park, CA
William Chen Managing Director 0 Shanghai, China
Yao Ho Managing Director Shanghai, China
You’re viewing 5 of 24 team members. Get the full list »

LYFE Capital Co-Investors (300)

Name With Exits Lead Partner Series Industry
HongShan 7 0 0 Series chart Industry bar
Lake Bleu Capital 0 0 0 Series chart Industry bar
Legend Capital 0 0 Series chart Industry bar
OrbiMed 0 0 0 Series chart Industry bar
Qiming Venture Partners 0 0 Series chart Industry bar
You’re viewing 5 of 300 co-investors. Get the full list »

LYFE Capital FAQs

  • What is LYFE Capital?

    Founded in 2015, LYFE Capital is a venture capital firm based in Shanghai, China.

  • When was LYFE Capital founded?

    LYFE Capital was founded in 2015.

  • Who is the founder of LYFE Capital?

    James Zhao MD and Drake Yu are the founders of LYFE Capital.

  • Where is LYFE Capital headquartered?

    LYFE Capital is headquartered in Shanghai, China.

  • What is LYFE Capital's total asset value?

    LYFE Capital has around 00.00 in total assets under management.

  • How many investments has LYFE Capital made?

    LYFE Capital has made 145 investments.

  • What has LYFE Capital invested in?

    LYFE Capital has made numerous investments in companies like Arnatar Therapeutics, ProfoundBio, and Neurona Therapeutics within the Drug Discovery and Biotechnology industries.

  • What has LYFE Capital invested in recently?

    LYFE Capital's latest investment was on 08-Apr-2024 in Arnatar Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »